Loading data for BNTC — first visit, this takes a few seconds.

Benitec Biopharma Inc. (BNTC)

NasdaqCM: BNTC · 即時價格 · USD

12.88

+0.57 (4.63%)

收盤價： Sep 04, 2026, 8:00 PM

12.68

+0.00%

盤後: 7:30 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

無可用資料

買價	8.95
市值	436M
營收 (ttm)	n/a
淨利（ttm）	-41.5M
	0.27
	-0.93
	n/a
	-1.35
P/B (ttm)	2.38
P/S (ttm)	0.00
財報日期	Sep 22, 2026

賣價	15.55
成交量	191,439
20 日平均成交量	139,907
開盤價	12.36
前收盤價	12.31
當日區間	12.25 - 13.18
52 週範圍	9.85 - 16.76
分析師	n/a
目標價	n/a
股利	n/a
除息日	n/a

關於 BNTC

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The com...

[閱讀更多]

產業 Biotechnology

類股 Healthcare

IPO 日期 Jun 24, 2014

員工 19

證券交易所 NasdaqCM

股票代號 BNTC

網站 https://benitec.com

完整的公司簡介

財務表現

Benitec Biopharma 在 2025 年的營收為 0，較前一年的 0 增加 undefined%。淨利為 -37.92M，較前期增加 74.32%。

財務報表

財報驚奇

Benitec Biopharma 已於 May 14, 2026 公布季度財報：

營收為 $0 低於預期 $0, 年增 NaN% 成長.
每股盈餘為 -0.24 超出預期 0.04, 年增 0.00% 成長.

下次財報發布

Benitec Biopharma Inc. 的下次財報預計於 Sep 22, 2026, 開盤前。
分析師預估營收 ... 升級

價格為何變動

新聞動態

7 月前 · Simply Wall St.

Here's Why We're Not At All Concerned With Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Situation

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

8 月前 · Zacks

Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 83.9% in Benitec Biopharma (BNTC). While the effectiveness of this highly sought-after metric is questionable, ...

9 月前 · Zacks

Wall Street Analysts Predict an 87.48% Upside in Benitec Biopharma (BNTC): Here's What You Should Know

The mean of analysts' price targets for Benitec Biopharma (BNTC) points to an 87.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amo...

9 月前 · Zacks

Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC)

Benitec Biopharma (BNTC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in ...

9 月前 · Insider Monkey

Citizens Lifts Benitec Biopharma Inc. (BNTC) Price Target on Topline Results for Oculopharyngeal Muscular Dystrophy Treatment

Benitec Biopharma Inc. (NASDAQ:BNTC) is one of the best breakout stocks to invest in. On November 4, an analyst at Citizens JMP raised the stock’s price target to $22 from $20 while reiterating an Out...

第 1 頁，共 2 頁

Benitec Biopharma Inc. (BNTC)